Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Edwards SAPIEN 3 Transcatheter Heart Valve Therapy for Intermediate Risk Patients

NCT03222128 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03222128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03222128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Edwards SAPIEN 3 Transcatheter Heart Valve Therapy for Intermediate Risk Patients
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Completed
Start date
February 17, 2014
Completion date
October 9, 2024
Enrollment
1,074 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic severe aortic stenosis